Insider filing · REPL
Sushil Patel
Director
profile →
Replimune Group, Inc.
REPL · Healthcare · 11 filings in 24 months
ticker →
Sushil Patel sold $510K of Replimune (REPL)
Executed Aug 10, disclosed Aug 12, 2 days later.
Value, as filed
$510K
39,341 sh × $12.97
Executed
Aug 10
the trade date, as filed
Disclosed
Aug 12
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SPSushil Patel (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Replimune Group, Inc. (REPL). The largest single filing was $919K of RVMD (4,880 sh across 6 lots, as filed), executed Jun 29.
The name
REPLHealthcare · Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapie…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Sushil Patel in REPL
REPLSALE
Replimune Group, Inc.
$190K37,324 sh × $5.08
Exec May 18
Filed May 20 · 5:30 PM ET REPLSALE Replimune Group, Inc. $111K
10,000 sh × $11.13
Exec Dec 2 2025
Filed Dec 4 2025 · 5:30 PM ET REPLSALE Replimune Group, Inc. $202K
25,105 sh × $8.06
Exec May 20 2025
Filed May 22 2025 · 5:30 PM ET REPLSALE Replimune Group, Inc. $124K
10,000 sh × $12.42
Exec Dec 16 2024
Filed Dec 18 2024 · 5:30 PM ET